专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

4. 发明授权

EP3558437B1 DELIVERY SYSTEM FOR INTENSITY MODULATED HIGH DOSE RATE BRACHYTHERAPY WITH INTERMEDIATE ENERGY BRACHYTHERAPY ISOTOPES 有权
公开(公告)号：EP3558437B1
公开(公告)日：2023-08-02
申请号：EP17883056.8
申请日：2017-12-20
发明人： ENGER, Shirin Abbasi Nejad , FAMULARI, Gabriel
IPC分类号： A61N5/10

6. 发明公开

EP3277665A1 INDOLE ANALOGS AS 5-OXO-ETE RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF 有权
标题翻译：吲哚类似物作为5-OXO-ETE受体拮抗剂及其使用方法
公开(公告)号：EP3277665A1
公开(公告)日：2018-02-07
申请号：EP16771139.9
申请日：2016-03-29
申请人： The Royal Institution for the Advancement of Learning / McGill University , Florida Institute of Technology
发明人： POWELL, William S. , ROKACH, Joshua
IPC分类号： C07D209/24 , A61K31/404 , C07C67/347 , C07C69/34
摘要： This invention relates to novel pharmaceutically-useful compounds, to methods for their preparation, and to pharmaceutical compositions and therapeutic methods for treating certain conditions.

7. 发明公开

EP3194960A1 BIOSENSORS FOR MONITORING BIOMOLECULE LOCALIZATION AND TRAFFICKING IN CELLS 有权
标题翻译：生物传感器监测细胞生物分子的定位和交通
公开(公告)号：EP3194960A1
公开(公告)日：2017-07-26
申请号：EP15841561.2
申请日：2015-09-21
申请人： The Royal Institution for the Advancement of Learning / McGill University , Université de Montréal
发明人： LAPORTE, Stéphane Alain , NAMKUNG, Yoon , BOUVIER, Michel , LE GOUILL, Christian , HOGUE, Mireille , LUKASHEVA, Viktoriya , KOBAYASHI, Hiroyuki , DEBLOIS, Denis , DURETTE, Etienne
IPC分类号： G01N33/53 , C12M1/34 , C12N15/62 , C12Q1/02 , C12Q1/66 , G01N33/58
CPC分类号： C07K14/723 , C07K2319/60 , G01N33/5035
摘要： Bioluminescence resonance energy transfer (BRET) biosensors for assessing the intracellular localization, internalization and trafficking into cellular compartments of proteins such as receptors, and other biomolecules such as second messengers, are disclosed. These biosensors, which are dependent on the concentration/density of the BRET donor and acceptor in cellular compartments rather that specific protein-protein interactions, use a Renilla GFP/Luc BRET pair, which allows the robust and reproducible monitoring of protein trafficking/localization, with a sensitivity compatible with high-throughput screening (HTS). The use of these biosensors for various applications, including assessing/monitoring protein endocytosis, recycling and intra-cellular trafficking, receptor maturation/rescue by pharmacological chaperones, various endocytosis/exocytosis processes, activation/inhibition, as well as biomolecule concentration/density in different cellular compartments, is also disclosed.
摘要翻译：公开了生物发光共振能量转移（BRET）生物传感器，用于评估细胞内定位，内化和运输到蛋白质如受体和其他生物分子如第二信使的细胞区室中。这些生物传感器依赖于细胞区室中BRET供体和受体的浓度/密度而非特定的蛋白质 - 蛋白质相互作用，使用Renilla GFP / Luc BRET对，其允许对蛋白质运输/定位的稳健和可重现的监测，灵敏度与高通量筛选（HTS）兼容。将这些生物传感器用于各种应用，包括评估/监测蛋白质内吞作用，再循环和细胞内运输，通过药理学分子伴侣的受体成熟/拯救，各种内吞作用/胞吐作用过程，活化/抑制以及不同细胞区室中的生物分子浓度/密度，也被披露。

8. 发明公开

EP3185746A1 VISION STRENGTHENING METHODS AND SYSTEMS 审中-公开
标题翻译：视觉强化方法和系统
公开(公告)号：EP3185746A1
公开(公告)日：2017-07-05
申请号：EP15837049.4
申请日：2015-08-27
申请人： The Royal Institution for the Advancement of Learning / McGill University
发明人： HESS, Robert F. , FARIVAR-MOHSENI, Reza , REYNAUD, Alexandre
IPC分类号： A61B3/08 , A61H5/00
CPC分类号： A61F9/00829 , A61B3/08 , A61F9/008 , A61F9/022 , A61F2009/00846 , A61H5/00 , A61H2201/165 , A61H2201/5007 , A61H2201/5043 , A61H2201/5097
摘要： Active dichoptic perceptual-learning tasks or dichoptic game play have been shown to significantly improve visual acuity of amblyopic children and adults. However, these dichoptic perceptual learning tasks are intensive and repetitive such that non-compliance is high. In contrast, the invention provides dichoptic perceptual learning in a manner that the user maintains its use and compliance is increased. Further, compliance becomes automatic if the user performs tasks in a normal manner and “forgets” that they are actually undergoing treatment as it is integrated with minimal disruption to their life and activities. Accordingly, a methodology exploiting complementary dichoptic stimulation is presented.
摘要翻译：主动分光感知学习任务或分光游戏已显示显着改善弱视儿童和成人的视力。然而，这些dichoptic知觉学习任务是密集的和重复的，因此不遵从性很高。相反，本发明以用户维持其使用并且遵从性增加的方式提供了分光学感知学习。此外，如果用户以正常方式执行任务并且“忘记”他们实际上正在接受治疗，则遵从性变为自动，因为它被整合在对他们的生活和活动的最小破坏中。因此，提出了一种利用补充分光刺激的方法。

9. 发明授权

EP1957986B1 INTRAOCULAR PRESSURE-REGULATED EARLY GENES AND USES THEREOF 失效转让
标题翻译：弗吉尼亚州麻省理工学院ZWISCHENAUGENDRUCK UND VERWENDUNGEN DAVON
公开(公告)号：EP1957986B1
公开(公告)日：2017-05-24
申请号：EP06844496.7
申请日：2006-11-22
申请人： McGill University
发明人： SARAGOVI, H., Uri
IPC分类号： G01N33/574 , C07K16/30 , C12N15/12 , C07K14/705 , A61K31/7088
CPC分类号： C07K16/18 , A61K2039/505 , C07K14/47 , C07K16/30 , C07K2317/76 , G01N33/5308 , G01N2800/168
摘要： The present invention relates to methods to treat glaucoma and glaucoma-related conditions through the regulation of changes in gene expression that are mediated by high intraocular pressure or alpha2 macroglobulin administration. Glaucoma, retinal ganglion cell (RGC) death and chronic ocular hypertension are treated using pharmaceutical compositions which comprise substances that inhibit the expression or activity of intraocular pressure-regulated early genes (IPREGs) or their gene products that are up-regulated by high intraocular pressure or alpha2 macroglobulin administration and/or which increase the expression or activity of IPREGs or their gene products that are down-regulated by high intraocular pressure or alpha2 macroglobulin administration. The invention also relates to methods of identifying an IPREG and methods to test for chronic ocular degeneration and the onset of RGC stress in an individual by measuring the expression level of IPREG proteins.
摘要翻译：本发明涉及通过调节由高眼内压或α2巨球蛋白给药介导的基因表达变化来治疗青光眼和青光眼相关病症的方法。使用药物组合物治疗青光眼，视网膜神经节细胞（RGC）死亡和慢性高眼压症，其包含抑制眼内压调节早期基因（IPREG）或其高眼内压上调的基因产物的表达或活性的物质或α2巨球蛋白施用和/或增加由高眼内压或α2巨球蛋白施用而下调的IPREG或其基因产物的表达或活性。本发明还涉及通过测量IPREG蛋白的表达水平来鉴定IPREG的方法和测试个体中慢性眼变性和RGC应激发作的方法。

10. 发明公开

EP3151873A1 BORATE-GLASS BIOMATERIALS 有权
标题翻译：硼酸盐玻璃生物材料
公开(公告)号：EP3151873A1
公开(公告)日：2017-04-12
申请号：EP15806709.0
申请日：2015-06-09
申请人： The Royal Institution for the Advancement of Learning / McGill University
发明人： NAZHAT, Showan N. , LEPRY, William Cole
IPC分类号： A61L27/02 , A61K33/00 , A61K8/19 , A61L27/56 , A61L31/02 , A61P17/02 , A61Q19/00 , C03C3/19 , C12N5/077
摘要： Borate-glass biomaterials comprising: aNa2O. bCaO. cP2O5. dB2O3 wherein a is from about 1-40 wt %, b is from about 10-40 wt %, c is from about 1-40 wt %, and d is from about 35-80 wt %; and wherein the biomaterial has a surface area per mass of more than about 5 m2/g. Methods of making and uses of these biomaterials.
摘要翻译：硼酸盐玻璃生物材料包括：aNa2O。 BCAO。 cP2O5。其中a为约1-40重量％，b为约10-40重量％，c为约1-40重量％，并且d为约35-80重量％并且其中生物材料具有大于约5m 2 / g的单位质量表面积。这些生物材料的制造和使用方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式